The Effects of the Telomerase Activator TA-65 on Insulin Resistance, Inflammation, and Metabolic Syndrome
Clinical trial NCT01753674 · TERMINATED
Trial details
- NCT number
- NCT01753674
- Sponsor
- University of Connecticut
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-01-01
- Primary completion
- 2014-06-01
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.